01 14GILEAD SCIENCES INC
02 8JANSSEN PRODS
03 7VIIV HLTHCARE
01 97125879
02 17390791
03 18129385
04 18592397
05 18716264
06 18754065
07 18841310
08 19242986
09 19296769
10 19457036
11 19744181
12 110426780
13 110857102
14 111065198
15 112011506
16 17125879*PED
17 17390791*PED
18 18129385*PED
19 18754065*PED
20 19242986*PED
21 19296769*PED
01 15Y
02 14Blank
01 23Y
02 6Blank
01 42024-01-13
02 12025-04-17
03 92025-04-21
04 12025-10-17
05 12025-10-21
06 12025-12-09
07 12027-10-05
08 12028-04-05
09 12029-12-08
10 12030-06-08
11 12031-01-24
12 22032-08-15
13 12033-01-14
14 22033-02-15
15 12037-10-23
16 12038-09-05
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2024-01-13
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8592397
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2025-12-09
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8841310
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-12-09
Patent Expiration Date : 2024-01-13
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 9457036
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2024-01-13
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8716264
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2024-01-13
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 9744181
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2024-01-13
Patent Expiration Date : 2025-04-21
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 7125879
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-04-21
Patent Expiration Date : 2025-04-21
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 7125879
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-04-21
Patent Expiration Date : 2033-01-14
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10857102
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-01-14
LOOKING FOR A SUPPLIER?
